Clinical trials
Phase 1 Lupus Erythematosus, Systemic trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| GlaxoSmithKline | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| Amgen | 1 |
| Autolus Limited | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics | 1 |
| Climb Bio, Inc. | 1 |
| Genentech, Inc. | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 20 |
| Arthritis, Rheumatoid | 5 |
| Myositis | 5 |
| Scleroderma, Systemic | 4 |
| Autoimmune Diseases | 3 |
| Connective Tissue Diseases | 3 |
| Dermatomyositis | 3 |
| Lupus Erythematosus, Cutaneous | 3 |
| Lupus Nephritis | 3 |
| Polymyositis | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.